Tepoxalin
![]() | |
![]() | |
| Systematic (IUPAC) name | |
|---|---|
|
3-[5-(4-Chlorophenyl)-1-(4-methoxyphenyl)pyrazol-3-yl]-N-hydroxy-N-methylpropanamide | |
| Clinical data | |
| AHFS/Drugs.com | International Drug Names |
| Routes of administration | Oral |
| Legal status | |
| Legal status |
|
| Identifiers | |
| ATCvet code | QM01AE92 (WHO) |
| PubChem | CID 59757 |
| ChemSpider | 53906 |
| UNII |
TZ4OX61974 |
| KEGG |
D06075 |
| ChEBI |
CHEBI:76277 |
| Chemical data | |
| Formula | C20H20ClN3O3 |
| Molar mass | 385.844 g/mol |
| |
| |
| | |
Tepoxalin is a nonsteroidal anti-inflammatory drug approved for veterinary use in the United States and many other countries.[1] It is primarily used to reduce inflammation and relief of pain caused by musculoskeletal disorders such as hip dysplasia and arthritis.[2]
It is generally marketed under the brand name Zubrin.[1]
See also
- Ipazilide
References
| ||||||||||||||||||||||||||||||||||||||
This article is issued from Wikipedia - version of the Tuesday, April 19, 2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.

